TickrTrends MDXG fair value analysis

MDXG Maintains Buy Rating by Craig-Hallum -- Price Target Raised to $8.00

gurufocus.com · 2026-08-27

MiMedx Group (MDXG) Analyst Rating Update On October 04, 2023, MiMedx Group (MDXG) received a maintained Buy rating from Craig-Hallum, with analyst Chase Kni

TickrTrends take: Craig-Hallum's maintained buy rating and raised price target for MDXG contrast with TickrTrends' current assessment that the Healthcare sector company is overvalued. A valuation-focused reader should monitor whether the analyst's increased confidence in the stock's prospects will narrow or widen the gap between market perception and TickrTrends' valuation metrics. The divergence between the buy recommendation and the overvalued designation suggests close attention to fundamental developments that could either justify upward revaluation or reinforce concerns about current pricing levels.

Read the full story at gurufocus.com →

Is MDXG undervalued? See TickrTrends' fair value analysis →